ArticleJournal for immunotherapy of cancer2022

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.

Xiaozhen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.